Therapy News and Research

RSS

Inadequate pain relief common in knee osteoarthritis

Patients with knee osteoarthritis requiring analgesic therapy are often not receiving adequate pain relief, researchers report.

8 Sep 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

Restarting infliximab therapy after drug holiday is safe for patients with IBD

Restarting infliximab therapy after a drug holiday is safe and effective for patients with inflammatory bowel disease (IBD), according to a new study1 in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

8 Sep 2014

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is combined with a powerful immunotherapy drug.

8 Sep 2014

Endo International introduces topical testosterone gel, FORTESTA Gel

Endo International plc announced today that it has introduced the first and only generic 2% topical testosterone gel, an authorized generic of FORTESTA® Gel (testosterone gel) CIII.

8 Sep 2014

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).

8 Sep 2014

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company's PulseRider® in Europe, the Middle East and Africa.

8 Sep 2014

New immuno-oncology drug helps body's own immune system to fend off cancer

According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.

8 Sep 2014

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company’s PulseRider in Europe, the Middle East and Africa.

8 Sep 2014

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin).

8 Sep 2014

PHI collaborates with Northeastern University for establishing novel cell analysis applications

Phase Holographic Imaging (PHI) today announces a collaboration agreement with Northeastern University of Boston.

8 Sep 2014

Scientists apply iPS cell technology to Huntington's disease transgenic monkey model

Creating induced pluripotent stem cells or iPS cells allows researchers to establish "disease in a dish" models of conditions ranging from Alzheimer's disease to diabetes.

8 Sep 2014

Combination miRNA therapy offers promising therapeutic avenue for non-small-cell lung cancer

Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.

8 Sep 2014

Researchers develop novel technique to promote tissue repair in damaged muscles

Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have developed a novel technique to promote tissue repair in damaged muscles.

8 Sep 2014

USF receives FEMA grant to reduce risk of low back pain, disability in firefighters

The University of South Florida's John Mayer, DC, PhD, recently received a $1.3 million Department of Homeland Security/Federal Emergency Management Agency Assistance of Firefighters grant - a three-year award that will help build upon cumulative research evaluating the effectiveness of targeted exercise programs to reduce the risk of low back pain and disability in firefighters.

6 Sep 2014

Researchers make important progress in defining new genetic causes of Wilms tumor

Researchers at UT Southwestern Medical Center and the Gill Center for Cancer and Blood Disorders at Children's Medical Center, Dallas, have made significant progress in defining new genetic causes of Wilms tumor, a type of kidney cancer found only in children.

6 Sep 2014

Peramivir drug safe, effective at alleviating influenza symptoms

An analysis of phase 2 and phase 3 clinical trials shows that a single injected dose of the neuraminidase inhibitor (NAI) peramivir is safe and effective at alleviating influenza symptoms, including fever and viral shedding, when administered within 48 hours of the onset of symptoms.

6 Sep 2014

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

6 Sep 2014

State highlights: Texas abortion clinic to reopen after ruling; Maine Medicaid cuts

An embattled abortion clinic in McAllen, Tex., which was the last provider of abortions in the vast Rio Grande Valley when new state restrictions forced it to stop last fall, will start operating again by this weekend, its owner said Wednesday, after last week's favorable decision by a federal judge (Eckholm, 9/3).

5 Sep 2014

Study: Innovative approaches required to decrease HIV transmission among Russian

Results of a new study conducted in St. Petersburg, Russia, show that decreasing HIV transmission among Russian HIV-infected drinkers will require creative and innovative approaches.

5 Sep 2014

Therapy News and Research

Inadequate pain relief common in knee osteoarthritis

Canada funds 22 inventive ideas for improving health in low-resource countries

Restarting infliximab therapy after drug holiday is safe for patients with IBD

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

Endo International introduces topical testosterone gel, FORTESTA Gel

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

New immuno-oncology drug helps body's own immune system to fend off cancer

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Soligenix acquires novel orphan drug candidate for treatment of CTCL

PHI collaborates with Northeastern University for establishing novel cell analysis applications

Scientists apply iPS cell technology to Huntington's disease transgenic monkey model

Combination miRNA therapy offers promising therapeutic avenue for non-small-cell lung cancer

Researchers develop novel technique to promote tissue repair in damaged muscles

USF receives FEMA grant to reduce risk of low back pain, disability in firefighters

Researchers make important progress in defining new genetic causes of Wilms tumor

Peramivir drug safe, effective at alleviating influenza symptoms

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

State highlights: Texas abortion clinic to reopen after ruling; Maine Medicaid cuts

Study: Innovative approaches required to decrease HIV transmission among Russian

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News